Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year

Aug 01 2018

• By Mandy Jackson

Finance Watch

Related Content

GW's Epidiolex Approval Encouraging For Pharma-grade Cannabinoid Pipeline

Jun 29 2018

Pipeline Watch – Updates From EULAR, EHA and ECNP

Jun 25 2018

Finance Watch: VC Investment Soars In Q1, Putting Biopharma On Track For A Record Year

Apr 15 2018

Deal Watch: Fresenius Drops Bid For Akorn, Citing Data-Integrity Concerns

Apr 23 2018

Allergan Aesthetic Medicines Head Moatazedi Moves To Emerging Competitor Evolus

May 08 2018

IPOs In Review: Biopharma Offerings Bounced Back In 2017 As Returns Rose

Jan 04 2018

Keeping Track: A Diverse Array Of Approvals, A CRL For Evolus' Botox Competitor, And Coherus Refiles Neulasta Biosimilar

May 20 2018

Keeping Track: We're Back!

Jan 19 2018

New EU Speedy Review Hopefuls: Novimmune, AveXis, bluebird bio, and Loxo Oncology

Jul 24 2018

Finance Watch: Happy Holidays For Flagship With A New $618m Fund

Dec 21 2017

Deal Watch: J.P. Morgan Brings Continued Brisk Pace Of Transactions

Jan 12 2017

Deal Watch: Success Nets CytomX Another $200m From BMS, Up To $3.6bn For Milestones

Mar 22 2017

IPO Update: Biopharma Firms Give Thanks For Receptive US Investors

Nov 24 2017

Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In

May 23 2017

Nabriva Gains New CEO And Near-Market Antibiotic, Claims Leadership Role

Jul 25 2018

Outlook For Reata's Bardoxolone Improves With Phase II Updates

Jul 24 2018

Finance Watch: VC Interest Lags At Early Stage – 'Hogwash' Or Evidence-Based?

Mar 06 2018

Pipeline Watch: Phase III Starts With QPI-1002, Enfortumab Vedotin And ZYN-002

Jul 13 2018

IPO Update: Returns Ride Rollercoaster Into Mid-Year As More Biopharmas Take The Plunge

Jul 04 2018

Roche’s Crenezumab Creeps Forward But Has All To Play For In Phase III Trials

Jul 26 2018

Bluebird 'Turns A Corner' With Lentiglobin Gene Therapy, Tests Remain

Jun 18 2018

Cara Therapeutics' Stock Buoyed By Positive Korsuva Data For Post-Op Pain

Jun 28 2018

Liquidia Technologies Inc.

Apr 01 2008

Takeda Paves The Way For Myovant With Phase III Fibroid Success

Oct 03 2017

Provention Builds On J&J Disease Interception Model

Sep 21 2017

Finance Watch: Former GSK CEO Witty, R&D Head Slaoui Join VC Firms

Sep 19 2017

Pipeline Watch: Phase III Progress With Esaxerenone, Lusutrombopag

Sep 29 2017

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Aug 02 2017

AC Immune Beefs Up Neurodegenerative Diseases Pipeline

Aug 24 2017

Rubius Prepares Off-The-Shelf Red Cell Therapies For First Human Trial In 2018

Oct 12 2017

Related Companies

Rubius Therapeutics, Inc.

Adial Pharmaceuticals, Inc.

Liquidia Corp.

Aquestive Therapeutics, Inc.

Crinetics Pharmaceuticals, Inc.

Allakos Inc.

Constellation Pharmaceuticals, Inc.

Provention Bio, Inc.

Replimune Group Inc.

Genetix Biotherapeutics

Idorsia Pharmaceuticals Ltd

Actelion Pharmaceuticals Ltd.

Johnson & Johnson

Reata Pharmaceuticals, Inc.

Assembly Biosciences, Inc.

CytomX Therapeutics, Inc.

Bristol Myers Squibb Company

AC Immune SA

Roche Holding AG

Cara Therapeutics, Inc.

Additional Topics

Financing Business Strategies Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window